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Abstract
Objective: The aim of this study was to determine the possible association of oxidant/antioxidant status and recur-
rent aphthous stomatitis (RAS). 
Study design: The study consis ted of thirty-one patients with RAS and thirty-two healthy controls from whom sa-
liva and blood samples were collected. Superoxide dismutase (SOD), glutathione peroxidase (GSHPx) and catalase 
(CAT) were measured in erythrocytes and total antioxidant status (TAS) was measured in plasma and saliva. 
Results: Erythrocyte SOD activity was significantly lower in RAS patients in comparison to healthy controls 
(P=0.012). No significant differences were found in erythrocyte GSHPx, CAT activities, and salivary and plasma 
TAS between RAS patients and control subjects (p>0.1). 
Conclusion: Changes in SOD activity may be important in the inflammatory reactions observed in RAS, but other 
tested defense systems such as CAT and GSHPx do not seem to play a primary role in the aetiopathogenesis of 
RAS. Moreover, the antioxidant system in saliva and plasma is not as affected as in erythrocytes in RAS patients, 
and therefore it may not be considered an appropriate indicator of the body’s total antioxidant status.
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Introduction
Recurrent aphthous stomatitis (RAS) is a common but 
poorly understood oral mucosal disorder that affects al-
most 20% of population worldwide (1,2). Clinical picture 
of RAS is defined by small, shallow, round or ovoid ul-
cerations, with well defined and circumscribed margins 
and with an erythematous halo around it. Ulcerations 
may be single or multiple and there have been described 
three types of aphthous ulcerations: minor, major and 
herpetiform. RAS occurs at intervals of few months to 
few days and heal spontaneously. It appears that it has 
some female predominance, white people are more af-
fected than black people and children of higher socio-
economic status are more commonly affected than those 
of lower socioeconomic groups (2-4).The exact cause of 
RAS has not been disclosed clearly. However, some etio-
logic and predisposing factors such as trauma, stress, ge-
netic, hypersensitivity, nutrition, immune disturbance, 
and hormonal imbalance are suggested (1-4). All of the 
above mentioned conditions can disturb the oxidant/
antioxidant balance of organism and can accelerate the 
formation of free radicals. Oxidative stress occurs when 
the intracellular concentrations of reactive oxygen radi-
cals (O2H2O2 and H2O2)  increase over the physiologic 
values. The cytotoxic effects of free radicals are de-
trimental for mammalian cells, and lead to cell dama-
ge through its damaging effects on peroxoidation of 
double-chain fatty acids, protein and DNA, as well as, 
increase oxidative stress (3,4).
Accordingly, mammalian cells have developed compli-
cated   antioxidant defense systems to prevent oxidative 
damage and to allow survival in an aerobic environ-
ment. This system includes enzymatic activities such 
as erythrocyte superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GSHPx), blood antioxi-
dant molecules as well as non-enzymatic antioxidants 
including vitamins A,C, E melatonin, and uric acid 
(UA) (5-8).
It has been reported in few studies that impaired oxidant/
antioxidant balance is responsible for the tissue damage 
in RAS patients (7-9). Regarding the insufficient stu-
dies pertinent to this issue, the aim of the present study 
was to measure some parameters of oxidative stress 
including erythrocyte superoxide dismutase, catalase, 
glutathione peroxidase, and the level of  salivary and 
blood oxidant/antioxidant status of RAS patients and 
compare it with healthy subjects to find new informa-
tion about RAS aetiopathology.
Materials and Methods
Patients
The institutional review board and Ethics Committee 
of Tehran University of Medical Sciences approved the 
study protocol and each subject signed a detailed in-
formed consent form. The study included 32 RAS cases 
who applied to outpatient clinic of oral medicine de-
partment of Tehran University of Medical Sciences and 
32 healthy individuals who age and sex were matched. 
The RAS patients had oral ulcer attack recurring at 
least three times a year and had active lesions during 
the study (1,10). RAS was diagnosed clinically by an 
expert in oral medicine. Patients were otherwise healthy 
and had active aphthous lesions during the study. They 
were not under a therapeutic regimen for the past 3 
months. The following laboratory tests were performed; 
erythrocyte sedimentation rate, blood cell counts and 
indexes; electrolytes, glucose, liver and kidney function 
tests, UA, calcium, phosphorus, globulin, albumin, iron 
in blood, vitamin B12 and folic acid. The patients with 
normal biochemical analysis mentioned above were par-
ticipated  into the study. Patients with Behçet s´ disease, 
chronic diarrhea, trauma history, any systemic disease, 
smoking history, alcohol drinking, or addiction were 
not included in the study.The control group included 32 
self-admitted healthy individuals that were either medi-
cal students or clinic staffs, who denied having RAS or 
using medications or vitamins.
Measurements
Analyses were carried out in saliva, plasma and eryth-
rocytes. Superoxide dismutase (SOD), catalase (CAT) 
and glutathione peroxidase (GSHPx) of erythrocyte, 
and total antioxidant status (TAS) of saliva and plasma, 
were measured. Activities of SOD, CAT and GSHPx in 
erythrocytes are expressed in international units, and 
TAS in saliva and plasma is expressed as mmol/L of 
plasma and saliva respectively.
Plasma preparation
Fasting venous blood samples (5 ml) from 31 patients 
and 32 healthy control individuals were drawn into va-
cutainers containing heparin as anticoagulant. Samples 
were centrifuged at 3000 g for 10 min at 4 ºC. Plasma 
was separated and buffy coat was discarded by aspi-
ration. Erythrocytes were washed four times with cold 
physiological saline and stored at − 40 °C until analy-
sis.
Saliva preparation
Samples were gained in the morning following an over-
night fast. The patients were first asked to rinse their 
mouth using distilled water. After 5 min, we started 
to gain unstimulated saliva samples. Then the patients 
were told to sit comfortably and to spit into the plastic 
tubes five times per min for 5 min. Samples were cen-
trifuged 4000 g for 10 min at 4 ºC, the upper parts were 
drawn and stored in small aliquots at - 40 ºC.  
Superoxide dismutase (SOD) and glutathione peroxi-
dase (GSHPx) activity 
The SOD and GSHPx activities of erythrocytes were es-
timated for the hemolyzsates by the use of commercially 
available kits RADSOD and RANSEL (Randox Labora-
tory Ltd., Ardmore, UK). The erythrocytes were hemo-
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lysed by the addition of ice-cold deionized water and vig-
orously vortexed. SOD estimation was based on the gen-
eration of superoxide radicals produced by xanthine and 
xanthine oxidase, which reacts with 2-(4-iodophenyl)-3
-(4-nitrophenol)-5-phenyl tetrazoliu-chloride (INT) to 
form a red formazan dye. The SOD activity was mea-
sured by the degree of inhibition of this reaction. 
Erythrocyte GSHPx determination was based on the 
following principle: GSHPx catalyzes the oxidation of 
glutathione by cumene hydroperoxide. In the presence 
of glutathione reductase and reduced nicotinamide ade-
nine dinucleotide, phosphate (NADPH) the oxidized 
glutathione (GSSG) is immediately converted to the re-
duced form with a contaminant oxidation of NADPH 
to NADP+. The decrease in absorbance at 340 nm was 
measured by a spectrophotometer (11,12). 
Erythrocyte catalase activity (CAT)
The CAT activity was measured in samples by method 
applied by  Cimen et al. (8). The decomposition of the 
substrate H2O2 was monitored spectrophotometrically 
at 240 nm. Specific activity was determined as micro-
mole substrate decomposed per minute per milligram of 
protein (i.e. U/mg protein).
Plasma and salivary total antioxidant status (TAS) 
The total antioxidant status of the plasma and saliva 
were measured using a recent automated colorimetric 
measurement method for the TAS developed by Erel 
(13).
In this method the hydroxyl radical, the most potent bio-
logical radical, is created by the Fenton reaction, and 
reacts with the colourless basis odianisidine to produce 
the dianisyl radical, which is bright yellowish-brown in 
colour. Upon the addition of a plasma and saliva sam-
ples, the oxidative reactions initiated by the hydroxyl 
radicals present in the reaction mix are suppressed by 
the antioxidant components of the plasma and saliva, 
hampering the colour change and thereby providing an 
effective measure of the total antioxidant capacity of the 
plasma and saliva. The analysis results are expressed 
as micromolar Trolox equivalent per liter (mmol Trolox 
eq./L), and the precision of this assay is excellent, being 
lower than 3% 9 (14). 
Statistical analysis 
All values were expressed as mean ± SD. Statistical 
analysis was performed by using chi-square and leven s´ 
test for equality of variances. For statistical analysis 
independent sample t-test and one-sample Kolmogrov 
Smirnov test were also used. Statistical significance 
was set at P<0.05.
Results
The patient group comprised 20 females and 11 males, 
whose mean age was 28.13± 8.05 years, while the control 
group consisted of 21 females and 11males, whose mean 
age was 27.09±7.54 years. The SOD, GSHPx, CAT in 
erythrocytes as well as plasma and salivary TAS values 
of RAS patients and controls are presented in table 1.
As seen in table 1, the comparison between the patient 
group and the control group showed that erythrocyte 
SOD activity was significantly lower in the former 
(P=0.012), but there was not a statistically significant 
difference between two groups in erythrocyte CAT 
(P=0.769), erythrocyte GSHPx (P=0.721), salivary 
TAS (P=0.971) and plasma TAS (P=0.311). The com-
parison between the TAS level in plasma and saliva in 
RAS group and the control group revealed that the level 
of TAS in plasma was significantly higher than saliva 
(P<0.01).
                          SOD
(U/mg 
protein)
CAT
(U/mg 
protein)
GSHPx
(U/mg protein)
TAS
(mmol/L 
plasma)
TAS
(mmol/L 
Saliva)
RAS 
(n = 31) 
1131.03 ± 
341.25
26.96 ± 
6.98
9515.09 ± 
3778.85
1.31 ± 
0.17
1.08 ± 
0.26
Control 
(n = 32) 
1417.68 ± 
515.91
27.56 ± 
8.94
9154.06 ± 
4199.70
1.36 ± 
0.20
1.08 ± 
0.34
P-value 0.012* 0.769 0.721 0.311 0.971
Table 1. Erythrocyte superoxide dismutase (SOD), catalase (CAT), glutathione  per-
oxidase (GSHPx) activities and total antioxidant status (TAS) levels in plasma and 
saliva of RAS patients and control subjects.
SOD, superoxide dismutase; CAT, catalase; GSHPx, glutathione peroxidase; TAS, 
total antioxidant status. Values are expressed as mean ± SD. * statistical significance 
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Discussion
Considerable activity of reactive oxygen radicals may 
lead to destroyed normal cell functions and integrity of 
cell structures. Oxidative stress in biological systems 
can be induced by the consumption of antioxidants and/
or by an overload of oxidant species, so that antioxi-
dant levels become deficient. It appears that imbalance 
between free radicals and antioxidants causes many 
inflammatory oral soft tissue diseases varying from 
infections and immunologic diseases to lethal cancers 
(4,6,8). In spite of a great deal of effort spent on this sub-
ject, few studies were reported in the literature investi-
gating the possible relation between RAS and oxidant/
antioxidant pathway (7-9).
The organism has enzymatic (e.g. superoxide dismutase, 
catalase, glutathione peroxidase) and non-enzymatic 
(e.g. vitamin C, vitamin E) antioxidant defense system 
that work as scavenger for this harmful reactive oxygen 
radicals. Radical scavenging antioxidants are  utilized 
by the increased free-radical activity associated with 
several conditions, and the amount of each antioxidant 
response has been used to indirectly evaluate free-radi-
cal activity (15-17).
In the present study, we investigated whether there is any 
alteration in SOD, GSHPx and CAT activity in eryth-
rocytes and TAS activity in plasma and saliva in RAS 
cases when compared with those of the control group. 
We found a slight decrease in CAT, a modest increase in 
GSHPx  activity and unchanged  activity of TAS. Only 
SOD activity altered significantly(P=0.012). 
SOD  is an enzyme that catalyzes the dismutation of two 
superoxide anions (O2-) into hydrogen peroxide and mo-
lecular oxygen. Superoxide dismutase defends the tissue 
to a certain degree from the harmful effects of superox-
ide radicals. There are two forms of SOD, Cu-Zn-SOD 
and Mn-SOD. A decreased level of SOD activity may be 
due to high consumption, and lead to overproduction of 
H2O2  that is a product of dismutation reaction. CAT hy-
drolyzes H2O2 into H2O and 1/2 O2 and recognized to be 
secondary antioxidant enzyme in peroxidative defense. 
In view of the fact that GSHPx is the dominant antioxi-
dant protective element participating in getting rid of 
H2O2 in the site, the increased amount of it may be due to 
genetic control mechanisms and feedback effects of H2O2 
on mRNA expression (18,19).
Moreover, we found slightly decreased blood TAS in 
RAS patients but we could not find any significant dif-
ference between salivary TAS of RAS patients and con-
trols. Although it was shown that only SOD is signifi-
cantly different in two groups, other values may show 
such difference with a larger sample size in further 
studies. So, it can be concluded that all of these changes 
and differences somehow the result of oxidant nature of 
the disease and again emphasizes such pathogenesis in 
patients with RAS.
Cimen et al. (8) measured SOD, GSHPx, and CAT acti-
vity in plasma and erythrocytes of patients with RAS 
and compared it with control group. They observed 
a relative reduction in CAT and GSHPx activity and 
AOP in erythrocytes of RAS patients and finally con-
cluded that enzymatic and non enzymatic antioxidant 
defenses in RAS patients are defective. Karincaoglu et 
al. (7) evaluated plasma and saliva antioxidant activity 
in patients with RAS and reported that SOD activity in 
plasma of RAS patients was lower than of control group 
(P<0.001). But Gunduz et al. (20) obtained exactly oppo-
site results. These relative controversies among studies 
may be associated with several factors including: sam-
ple size variations, application of various methods and 
genetic divergence of each population. Furthermore, the 
composition and antioxidant capacity may vary by die-
tary and nutrient deficiency.
In recent years, there are increasing reports on literature 
regarding application of natural anti oxidant products 
on management of RAS. These herbal preparations in-
cluding extracts and/or essential oils of medicinal plants 
exhibits promising effects on shortening healing time 
and severity of pain in RAS patients (1). On the other 
hand, food, dietary and nutrient deficiency has impor-
tant role in human health and as an initiating factor in 
RAS (1-3). Among these material antioxidant vitamins 
and micro-elements such as zinc and selenium consid-
ered more attention because they are involved in anti-
oxidant defense system (8).
It can be concluded that antioxidant system in saliva and 
plasma is not as affected as in erythrocytes in RAS pa-
tients and therefore it may not be considered an appro-
priate indicator of total antioxidant status of the body. 
Nevertheless, neither present study nor previous ones 
could categorically conclude, either is it that the antioxi-
dant system impairment in RAS patients causing aph-
thae, or vice versa, the full antioxidant impairment in 
aphthous patient is the consequence of aphthous ulcers. 
We propose that future studies should be controlled, 
multicenter prospective studies ,which shall include 
large case series and this issue should be conducted. 
The results may be very useful in founding new treat-
ments using antioxidant supplementation or nutritional 
prescriptions that might elevate antioxidant system level 
in RAS patient.
References
1. Babaee N, Mansourian A, Momen-Heravi F, Moghadamnia A, 
Momen-Beitollahi J. The efficacy of a paste containing Myrtus com-
munis (Myrtle) in the management of recurrent aphthous stomatitis: 
a randomized controlled trial. Clin Oral Investig. 2010;14:65-70. 
2. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod. 1996;81:141-7. 
3. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. 
Crit Rev Oral Biol Med. 1998;9:306-21. 
4. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and manage-
Med Oral Patol Oral Cir Bucal. 2010 Jul 1;15 (4):e557-61.                                                                                                                                                    Salivary and serum antioxidant in aphthae
e561
ment of recurrent aphthous stomatitis: a consensus approach. J Am 
Dent Assoc. 2003;134:200-7. 
5. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial func-
tion and oxidative stress mechanisms in patients with Behçet’s syn-
drome. J Am Coll Cardiol. 2001;37:517-20. 
6. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress 
and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin 
Oncol. 2004;34:379-85. 
7. Karincaoglu Y, Batcioglu K, Erdem T, Esrefoglu M, Genc M. The 
levels of plasma and salivary antioxidants in the patient with recur-
rent aphthous stomatitis. J Oral Pathol Med. 2005;34:7-12. 
8. Cimen MY, Kaya TI, Eskandari G, Tursen U, Ikizoglu G, Atik U. 
Oxidant/antioxidant status in patients with recurrent aphthous sto-
matitis. Clin Exp Dermatol. 2003;28:647-50. 
9. Cağlayan F, Miloglu O, Altun O, Erel O, Yilmaz AB. Oxidative 
stress and myeloperoxidase levels in saliva of patients with recurrent 
aphthous stomatitis. Oral Dis. 2008;14:700-4. 
10. Albanidou-Farmaki E, Deligiannidis A, Markopoulos AK, Kat-
sares V, Farmakis K, Parapanissiou E. HLA haplotypes in recurrent 
aphthous stomatitis: a mode of inheritance? Int J Immunogenet. 
2008;35:427-32. 
11. Battin EE, Brumaghim JL. Antioxidant activity of sulfur and se-
lenium: a review of reactive oxygen species scavenging, glutathione 
peroxidase, and metal-binding antioxidant mechanisms. Cell Bio-
chem Biophys. 2009;55:1-23. 
12. Durmaz A, Dikmen N. Homocysteine effects on cellular glutath-
ione peroxidase (GPx-1) activity under in vitro conditions. J Enzyme 
Inhib Med Chem. 2007;22:733-8. 
13. Erel O. A new automated colorimetric method for measuring to-
tal oxidant status. Clin Biochem. 2005;38:1103-11. 
14. Cao G, Prior RL. Comparison of different analytical methods 
for assessing total antioxidant capacity of human serum. Clin Chem. 
1998;44:1309-15. 
15. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, 
Kahn E, et al.  Increased oxidative stress and decreased antioxidant 
defenses in mucosa of inflammatory bowel disease. Dig Dis Sci. 
1996;41:2078-86. 
16. Sezer E, Ozugurlu F, Ozyurt H, Sahin S, Etikan I. Lipid peroxi-
dation and antioxidant status in lichen planus. Clin Exp Dermatol. 
2007;32:430-4. 
17. Hoelzl C, Bichler J, Ferk F, Simic T, Nersesyan A, Elbling L, et al. 
Methods for the detection of antioxidants which prevent age related 
diseases: a critical review with particular emphasis on human inter-
vention studies. J Physiol Pharmacol. 2005;56 Suppl 2:49-64. 
18. Miao L, St Clair DK. Regulation of superoxide dismutase genes: 
implications in disease. Free Radic Biol Med. 2009;47:344-56. 
19. Dalton TP, Shertzer HG, Puga A. Regulation of gene expression 
by reactive oxygen. Annu Rev Pharmacol Toxicol. 1999;39:67-101. 
20. Gunduz K, Ozturk G, Sozmen EY. Erythrocyte superoxide dis-
mutase, catalase activities and plasma nitrite and nitrate levels in 
patients with Behçet disease and recurrent aphthous stomatitis. Clin 
Exp Dermatol. 2004;29:176-9. 
Acknowledgments
This work was supported by a grant from the Research Council of the 
Tehran University of Medical Sciences. 
